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Background and Purpose—It would be essential to clinicians, familial aneurysm study groups, and aneurysm families to
understand the genetic basis of subarachnoid hemorrhage (SAH), but there are no large population-based heritability
estimates assessing the relative contribution of genetic and environmental factors to SAH.
Methods—We constructed the largest twin cohort to date, the population-based Nordic Twin Cohort, which comprised
79 644 complete twin pairs of Danish, Finnish, and Swedish origin. The Nordic Twin Cohort was followed up for 6.01
million person-years using nationwide cause-of-death and hospitalization registries.
Results—One hundred eighty-eight fatal and 321 nonfatal SAH cases were recorded in the Nordic Twin Cohort. Thus,
SAH incidence was 8.47 cases per 100 000 follow-up years. Data for pairwise analyses were available for a total of 504
SAH cases, of which 6 were concordant (5 monozygotic and 1 opposite sex) and 492 discordant twin pairs for SAH.
The concordance for SAH in monozygotic twins was 3.1% compared with 0.27% in dizygotic twins, suggesting at most
a modest role for genetic factors in the etiology of SAH. The population-based probability estimate for SAH in dizygotic
siblings of a patient with SAH is 0.54%, and only 1 of 185 full siblings experience familial SAH. The corresponding
risk of SAH in monozygotic twins is 5.9%. Model-fitting, which was based on the comparison of the few monozygotic
and dizygotic pairs, suggested that the estimated heritability of SAH is 41%.
Conclusions—SAH appears to be mainly of nongenetic origin, and familial SAHs can mostly be attributed to
environmental risk factors. (Stroke. 2010;41:2458-2462.)
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The incidence of subarachnoid hemorrhage (SAH) ofapproximately 7.8 cases per 100 000 person-years in
non-Finnish countries1 together with a 30-day mortality rate
of 40% to 60% ranks SAH among the deadliest vascular
emergencies. Compared with most Western countries, the
risk of SAH is nearly 3 times as high (incidence 21.4 per
100 000 person-years) in Finland,1 the reason for which
remains unclear. Up to 90% of spontaneous SAH cases are
due to rupture of an intracranial aneurysm.2 Important mod-
ifiable risk factors for SAH include cigarette smoking (rela-
tive risk, 2.2 to 3.1), high blood pressure (relative risk, 2.5 to
2.6), and heavy (150 g/week) alcohol consumption (relative
risk, 1.5 to 2.1).3 It has been estimated that the population-
attributable risk of cigarette smoking is 20% for SAH,
whereas high blood pressure accounts for 17% and alcohol
abuse for 11% to 21% of SAHs.4
Familial risk is defined as the probability of a healthy
family member being affected by the same disease, which has
already affected at least 1 other family member. Familial risk
of SAH depends on a number of factors, including especially
genetic and environmental factors as well as the number and
ages of relatives at risk. In general, any population-based
heritability estimate value of 50% indicates that environ-
mental variance is greater than genetic variance. Given the
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relatively low population-based incidence of SAH, it has been
a challenge to estimate the genetic risk of SAH in relatives,
the resolution of which could have significant implications on
prophylactic screening protocols of intracranial aneurysms.
Family history of SAH in first- and second-degree relatives
has been reported to be a significant nonmodifiable risk factor
with a 6.6-fold hazard ratio,5 accounting for 11% of the
population-attributable risk for SAH.4
Large twin cohorts provide a “shortcut” to carry out the
estimation of heritability, defined as the proportion of the
variance on an underlying liability to disease that is due to
genomic effects and of environmentality, the proportion due
to environment. Indeed, twin studies have been described as
“the perfect natural experiment to separate familial resem-
blance from genetic influence,”6 and large population-based
twin studies can provide the best epidemiological evidence of
familial clustering of any disease. Because of this, in an
attempt to clarify the role of genetics in SAH, we performed
the largest classical twin study to date consisting of Danish,
Finnish, and Swedish population-based twin registers, which
together comprised over 160 000 twin siblings.
Subjects and Methods
Study Subjects
Twin cohorts from Denmark, Finland, and Sweden have been
described previously,7–10 and these cohorts comprise the Nordic
Twin Cohort. In brief, Finnish, Swedish, and Danish population-
based cohorts have existed for many decades and they include
virtually all the same-sex twins in the relevant birth cohorts, whereas
the Danish cohort comprises not only same-sex, but also opposite-
sex twins. The follow-up mortality data were obtained by linkage to
computerized nationwide cause-of-death databases using the unique
personal identifiers assigned to each citizen in each country. Nonfa-
tal SAH cases were derived from national hospital discharge regis-
ters, which cover virtually the whole populations of the countries in
the study. The data were available up to the end of 2001 in Denmark
and Sweden and up to the end of 2003 in Finland for fatal SAH. For
nonfatal Finnish SAH cases, the data were updated at the end of
1995. The pooled data comprised 79 664 complete twin pairs and
160 438 individuals including a small number of twins with missing
information on their cotwin. Of all subjects, 51% were women.
Incident cases of SAH as well as all deaths with the underlying cause
of death coded as an SAH or hospitalization for an SAH (the main
cause) were classified as cases. After an SAH (fatal or nonfatal) in a
twin, the median follow-up time for the cotwin was computed as the
time until an SAH (fatal or nonfatal) occurred, emigration, or end of
follow-up. Characteristics of the twin cohorts are presented in Table 1.
Determination of Zygosity
For all 3 national cohorts, zygosity was determined by standardized
questionnaire methods. The questionnaire methods have been vali-
dated,11–13 and they correctly classify 95% of twin pairs as
monozygotic (MZ) or dizygotic (DZ).
Data Analysis
Nonfatal and fatal SAHs were recorded during the follow-up time,
which was different for every cohort (Table 1). Twin pairs were
defined as discordant twin pairs for SAH if only 1 twin had an SAH
during the follow-up time regardless of whether the cotwin had died
from another cause. Twin pairs were concordant for SAH if both
twins had an SAH. Sex, zygosity, and age effects on the incidence of
SAH were tested by a Cox proportional hazard model, for which the
follow-up time was calculated from the time point of the baseline
measurement to the date of SAH, death from other causes, emigra-
tion, or the end of the follow-up period. The effect of the twin pair
sample design was taken into account using the cluster option of the
Stata statistical package (Version 9.2). The analyses were adjusted
for birth date. Study cohort and sex in the pooled analyses for men
and women were included as a stratum variable, that is, allowing its
own baseline hazard for each group. Proportional hazard assump-
tions of SAH incidence were not violated for zygosity (P0.60) or
sex (P0.40) when tested using Schoenfeld residuals.
Risk and Genetics of SAH
Two different estimators of the familial risk of SAH were used. To
estimate the risk that a twin is affected given an affected cotwin,
probandwise concordance was computed by dividing the number of
cases among concordant twin pairs by the total number of cases.14
All cases were ascertained independently, and estimates were com-
puted separately for MZ and DZ pairs. The tetrachoric correlation of
the pairwise (twin 1 versus twin 2 and affected versus unaffected,
2-by-2 table) distribution of cases in MZ and DZ pairs was computed
as an estimate of the underlying, latent liability to SAH based on a
threshold model of the disease.15 Based on these contingency tables
from MZ and DZ tables, standard model-fitting methods for additive
genetic and environmental components of variance were fit using the
Mx, a program for analysis of twin and family data.16,17 All other
analyses were done using the Stata statistical package (Version 9.2).
Results
The total number of twin subjects with SAH in the Nordic
Twin Cohort was 509, but the follow-up data of cotwins were
not available for 5 patients, and they were thus excluded from
all pairwise analyses. The follow-up time was 6.01 million
person-years for all individuals (Table 2). Of 509 twins with
an SAH, 295 (58%) were female and 214 (42%) were male.
SAH incidence in the Nordic Twin Cohort was 8.47 cases per
100 000 follow-up years (26.74, 12.43, 15.56, and 4.27 cases
Table 1. Characteristics of the Nordic Twin Cohort
Danish
Same-Sex Cohort
Danish
Opposite-Sex Cohort Finnish Cohort
Swedish
Older Cohort
Swedish
Younger Cohort
Year of birth 1870–1970 1870–1970 1880–1957 1886–1925 1925–1958
Baseline data collection Varies Varies 1975 1963 1972
Mean age in years at baseline (range) Not applicable Not applicable 36 (18–95) 49 (36–75) 28 (14–46)
End of the follow-up 12/31/2001 12/31/2001 12/13/2003
12/31/1995
12/13/2001 12/31/2001
No. twin individuals 52 386 27 530 26 326 21 163 32 495
No. complete pairs 26 184 13 765 12 898 10 581 16 236
Females, % 48 50 51 56 52
Monozygotic twins, % 35 0 31 35 39
*Hospitalized cases of SAH.
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per 100 000 follow-up years in the Finnish, Swedish younger,
Swedish older, and Danish cohorts, respectively; if the
follow-up for the Danish cohort is started after the age of 20
years, the incidence is 7.16 cases per 100 000 follow-up
years; see the Figure). The hazard ratio for women compared
with men was 1.36 (95% CI, 1.10 to 1.69) for SAH incidence,
whereas no difference in age- and sex-adjusted SAH inci-
dence and mortality was found between MZ and DZ twin
individuals in the pooled data (P0.09 and P0.24, respec-
tively). The median age at SAH diagnosis was 53.6 years
(interquartile range, 43.0 to 65.5 years; Table 2).
We identified only 6 twin pairs (12 twin subjects) concor-
dant for SAH, and 5 of these were MZ twin pairs (Table 2).
Patient characteristics for the concordant twin pairs are
depicted in Table 3. In the 6 concordant pairs, the median
time between the onset of SAH in both twin siblings was 3.5
years (range, 0 to 13 years). In comparison, the median
follow-up time for all cotwins after SAH in the other twin
(index case) was nearly 3-fold (9.7 years; interquartile range,
3.5 to 16.3 years; Table 2), which implies that a longer
follow-up would unlikely show more concordant pairs. The
probandwise concordance for all cases was 5.9% in MZ pairs.
Furthermore, the tetrachoric correlation in liability was 0.42
(95% CI, 0.24 to 0.56). For DZ pairs, the probandwise
concordance was 0.54%, and the tetrachoric correlation in
liability was 0.054 (95% CI, 0.0 to 0.26). Of the 492
discordant twin pairs (147 MZ and 345 DZ pairs), 184 (55
MZ and 129 DZ pairs) were discordant for fatal SAH (Table
2). Based on the comparison of the few MZ and DZ pairs,
model-fitting estimate of heritability was 41% (95% CI,
23.7% to 55.5%).
Discussion
In this first and only large population-based heritability study
assessing the relative contribution of genetic factors to SAH,
we identified only 6 (1.2%) concordant pairs (5 MZ and
opposite sex) of 498 twin pairs with SAH. Only 1 concordant
MZ pair was relatively young at the time of SAH. The
probandwise concordance value of 0.54% for DZ twins
depicts the probability (recurrence risk) of SAH in full (same
father and mother) singleton siblings, who, like DZ twins,
share 50% of their segregating genes. This means that in
families with 1 SAH patient, only 1 of 185 siblings experi-
ences SAH. For MZ twins, who share, in addition to the
genetic sequence, numerous environmental exposures and
experiences, the probandwise concordance value was 5.9%,
which means that every 17th MZ twin will experience an
SAH after an occurrence of an SAH in the cotwin. The MZ
tetrachoric correlation value (42%) implies a moderate size
Table 2. Follow-Up Times of the Cohorts, Concordant Twin Pairs for SAH, the Median Age at Diagnosis of
Nonfatal SAH, and the Median Age of Death From SAH Among the 79 664 Twin Pairs
Danish
Same-Sex Cohort
Danish
Opposite-Sex Cohort Finnish Cohort
Swedish
Older Cohort
Swedish
Younger Cohort
Follow-up time, million
person-years
2.58 1.24 0.65
0.51*
0.60 0.94
No. fatal SAH cases 29 19 60 49 31
No. concordant fatal pairs 0 1 0 0 1
No. all SAH cases 96 67 137 93 116
No. concordant pairs 2 1 0 2 1
Age of death from SAH in
years and IQR†
57.9 (47.5–72.1) 46.0 (41.3–51.6) 56.1 (46.7–68.2) 69.5 (62.8–78.1) 50.0 (39.7–54.3)
Age at diagnosis of all SAHs
in years and IQR†
54.5 (41.8–66.8) 46.0 (38.3–52.3) 51.9 (41.0–64.9) 69.8 (63.5–77.4) 50.0 (41.0–56.9)
Cotwin follow-up time in
years and IQR†
7.9 (4.3–13.5) 8.9 (3.8–16.3) 8.6 (5.6–19.0) 12.6 (6.7–18.0) 10.2 (3.8–19.8)
*Hospitalized cases of SAH.
†Median together with interquartile range (IQR) (ie, lower 25th percentile and upper 75th percentile quartiles).
Figure. Kaplan–Meier survival estimates of the study cohorts.
Table 3. Patient Characteristics of Concordant Twin Pairs
Nationality Zygosity Sex Age at Death Age at SAH Diagnosis
Denmark DZ M/F 53/52 53/52
Denmark MZ M/M 49/48 48/48
Denmark MZ M/M …/… 72/68
Finland MZ F/F 65/77 64/72
Finland MZ F/F 85/87 85/82
Swedish young MZ F/F 34/21 34/21
M indicates male; F, female.
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broad-sense heritability (additive and nonadditive factors),
which can result from additive genetic effects, genetic effects
due to dominance, and genome–environment interaction
effects shared by the twins. If the heritability was due only to
additive genetic effects, the tetrachoric correlation in the DZ
pairs should be 0.21. However, it was considerably lower
(0.054), which implies the presence of effects due to domi-
nance or the combination of genes at multiple loci. Model-
fitting based on the comparison of the few MZ and DZ pairs
showed that the estimated heritability was 41% (95% CI,
23.7% to 55.5%), which is very similar to the MZ tetrachoric
correlation value. Previously, we have reported that the
estimated heritability for prostate cancer, colorectal cancer,
and breast cancer is 42%, 35%, and 27%, respectively.10
The strengths of our study include: (1) the population-
based study cohorts with both fatal and nonfatal SAH cases;
(2) the exceptionally large number of twins surveyed; (3) the
satisfactory number of SAH events found among twins; (4)
the reliable estimate of the incidence rate of SAH (8.47 cases
per 100 000 follow-up years) in comparison with previous
reports; 5) the long-term (almost lifetime) prospective
follow-up of unaffected cotwins; 6) the similar centralized
and high-quality cause-of-death and hospitalization registers,
which have been widely used in thousands of previous studies
in Nordic countries; and 7) the presence of the middle-aged
large birth cohort. Because being a sibling of an affected
relative has been reported to increase the risk of having an
aneurysm or SAH more than being a parent or child,18–20 the
strength of evidence from our study of twin siblings is even
more significant. The fact that twins are siblings of the same
age eliminates the possibility of large phenotypic differences
related to age differences, which complicate the analyses of
genetic studies in singleton siblings and nuclear families. In
addition, the systematic ignoring of extramarital paternity in
family-based studies of heritability may result in some bias,
whereas twin siblings rarely have different fathers.
The major drawbacks include the following: (1) discordant
cotwins were not traced (practically impossible) to check
whether preventive treatments for SAH had been given; (2)
the relatively small proportional representation of young
(25 years of age) individuals in the cohorts; (3) surviving
discordant cotwins were not invited to have an MRI angio-
gram to estimate the familial prevalence of aneurysms (which
was not the purpose of this study); and (4) register-based
diagnoses may contain errors. It is very unlikely that a
significant number of endo- or exovascular procedures had
been conducted before the rupture of an aneurysm to prevent
a SAH in a discordant cotwin because 62% of the SAH
incidents happened before 1993 when screening of family
members was not a routine procedure nor a recommendation
in Nordic countries. We believe that it is highly unlikely that
the possible ignoring of rare events of SAHs at young ages
may have affected our conclusions drawn.
Due to inevitable difficulties in conducting epidemiologi-
cal studies on a rare, dichotomous and complex disease trait,
some methodological shortcomings may have influenced
previous interpretations. It has been virtually impossible to
conduct a large enough population-based familial SAH study
containing multiple affected individuals and longitudinal
(several decades of follow-up) family data. Such a study
cannot be done either at present or in the future, because
many unruptured familial and incidental intracranial aneu-
rysms are currently treated. Previous reports suggest that
familial (at least 1 first-degree relative with SAH) occurrence
of SAH is an important nonmodifiable risk factor for
SAH.5,20–22 Understandably, none of these studies have been
able to control (1) risk factors (ie, confounding factors
including cigarette smoking, high blood pressure, heavy
alcohol consumption) among study and control subjects; (2)
the number of full-sisters and other first-degree family
members of the cases and control subjects when reporting
incidence of SAH in families; and (3) consanguinity among
family members. In accordance with our results, a recent
large population-based (hospital-admitted, mainly nonfatal
index cases) case–control (matched for age and sex, not for
risk factors) study of the risk of familial SAH reported that
only 10 (0.19%) of 5282 hospital-admitted patients with SAH
have 2 first-degree relatives with an SAH (ie, 3 patients
with SAH in the family), and 156 (2.95%) patients with SAH
have 1 affected first-degree relative in the family.23 In total,
only 166 (3.14%) of 5282 patients with SAH have 1
affected first-degree family members.23 The OR (not relative
risk) of familial SAH for individuals with 1 affected
first-degree relatives was 2.28 when compared with age- and
sex-matched control subjects (ie, no adjustment for, for
example, confounding risk factors), of which 1.41% had SAH
cases in the family.23 If the lifetime relative risk of SAH of a
family member was 2-fold or even 15-fold higher than in the
general population, for which the lifetime risk has been
estimated to be 0.7%,23 the absolute lifetime risk of SAH
would be 1.4% and 10.5%, respectively. The recent
population-based data suggest an absolute lifetime risk of
SAH of 26% (OR, 51.0) for individuals with 2 first-degree
relatives with SAH.23 This very high lifetime risk estimate
surely warrants screening programs for these rare SAH
families.
Our results with the heritability estimate of 41% suggest
that there is a moderate role for genetic factors in the etiology
of SAH, whereas environmental factors play a significant role
in SAH susceptibility at the population level. This relatively
low heritability estimate for a complex trait suggests that very
large genomewide association studies, similar to recent stud-
ies of intracranial aneurysms,24,25 or whole genome linkage
studies are necessary to identify genomic variants and candi-
date genes underlying the risk for SAH. Alternatively, genetic
studies should focus on identifying rare variants in the
families with multiple affected members.
Summary
In brief, our results together with the previous results23
suggest that a positive family history accounts for, at the
most, only a small percentage of SAHs, not for 11% of the
population-attributable risk for SAH.4 Of these rare familial
SAH cases, possibly only a minority is due to the clustering
of susceptibility genes. It is conceivable that familial cluster-
ing of confounding risk factors (eg, cigarette smoking, high
blood pressure, and heavy alcohol consumption) makes a
significant contribution to previously reported incidence rates
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of familial SAHs. On the basis of current evidence, screening
of familial aneurysms may be warranted at least for first-degree
family members with2 SAHs in the family and to a monozy-
gotic sibling of a MZ twin with a positive history of SAH.
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Abstract 17
自然発症くも膜下出血の遺伝疫学— 北欧双生児研究
Genetic Epidemiology of Spontaneous Subarachnoid Hemorrhageke ― Nordic Twin Study
Miikka Korja, MD, PhD1; Karri Silventoinen, PhD2; Peter McCarron, MD, PhD3; Slobodan Zdravkovic, 
PhD4; Axel Skytthe, PhD5; Arto Haapanen, MD, PhD6; Ulf de Faire, MD, PhD4,7; Nancy L. Pedersen, MD, 
PhD8; Kaare Christensen, MD, PhD5; Markku Koskenvuo, MD, PhD2; Jaakko Kaprio, MD, PhD2,9,10; the 
GenomEUtwin Project
1 Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland; 2 Department of Public Health, University of Helsinki, 
Helsinki, Finland; 3 Department of Epidemiology and Public Health, Queen’s University Belfast, Belfast, UK; 4 Division of Cardiovascular 
Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; 5 Danish Twin Registry, Institute of Public Health, 
University of Southern Denmark, Odense C, Denmark; 6 Department of Radiology, Turku University Hospital, Turku, Finland; 7 Department of 
Cardiology, Karolinska University Hospital, Stockholm, Sweden; 8 Department of Medical Epidemiology and Biostatistics, Karolinska Institute, 
Stockholm, Sweden; 9 Department of Mental Health, National Institute for Health and Welfare, Helsinki, Finland; 10 Institute for Molecular 
Medicine FIMM, Helsinki, Finland.
Abstract
背景および目的：医師や家族性動脈瘤研究グループ，動脈
瘤の家系に属する人々にとって，くも膜下出血（SAH）の
遺伝的基盤を理解することは不可欠であると考えられる。
しかし，一般住民を対象にSAHに対する遺伝的要因と環
境要因の相対的寄与率を検討し，遺伝率を推定した大規模
研究は行われていない。
方法：北欧双生児コホートは，一般住民を対象とした過去
最大規模の双生児コホートであり，デンマーク，フィンラ
ンド，スウェーデンで生まれたすべての双生児 79,644 組
で構成されている。この北欧双生児コホートを対象に，全
国死因登録簿および入院登録簿を用いて，合計 601 万人・
年の追跡調査を行った。
結果：北欧双生児コホートから致死的SAH 188 例および
非致死的SAH 321 例の記録が得られた。100,000 追跡調
査年あたりのSAH発症率は 8.47 件であった。合計 504
組の SAH症例についてペア解析のデータが得られ，この
うち 6組はともにSAHを発症し（5組は一卵性，1組は異
性の二卵性），492 組は一方のみがSAHを発症していた。
SAHの一致率は，一卵性双生児が 3.1％，二卵性双生児が
0.27％で，SAH発症における遺伝的要因の役割はさほど
大きくないと思われた。二卵性双生児の場合，一般人口の
値に基づき推定した患者の同胞のSAH発症確率は 0.54％
であり，同胞 185 例のうち 1例が家族性SAHを発症す
る程度である。これに対し，一卵性双生児の場合の上記
リスク値は 5.9％であった。このように少数の一卵性双生
児と二卵性双生児の比較に基づきモデルを構築した結果，
SAHの遺伝率は 41％と推測された。
結論：SAHは主に遺伝以外の原因によって生じるようで
あり，家族性SAHは主として環境危険因子に起因してい
ると考えられる。
Stroke 2010; 41: 2458-2462
表3 ともにSAHを発症した双生児の患者特性
国籍
一卵性／
二卵性 性別 死亡年齢
SAH
診断年齢
デンマーク DZ M/F 53/52 53/52
デンマーク MZ M/M 49/48 48/48
デンマーク MZ M/M …/… 72/68
フィンランド MZ F/F 65/77 64/72
フィンランド MZ F/F 85/87 85/82
スウェーデン若年層 MZ F/F 34/21 34/21
MZ：一卵性，DZ：二卵性，M：男性，F：女性。
図 本研究コホートのKaplan‒Meier 生存推定値。
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